Endometrial tumor immune response: Predictive biomarker of response to immunotherapy

Mary M. Mullen, David G. Mutch

Research output: Contribution to journalArticlepeer-review

3 Scopus citations

Abstract

The tumor-specific immune response in endometrial cancer is variable within molecular subtypes. Thus, the tumor immune response offers a novel biomarker, separate from molecular subtypes, to predict which patients might respond to immunotherapy.

Original languageEnglish
Pages (from-to)2366-2368
Number of pages3
JournalClinical Cancer Research
Volume25
Issue number8
DOIs
StatePublished - Apr 15 2019

Fingerprint Dive into the research topics of 'Endometrial tumor immune response: Predictive biomarker of response to immunotherapy'. Together they form a unique fingerprint.

Cite this